Analyzing clinical laboratory data outcomes in retrospective cohort studies using TriNetX
Joshua Wang1, Kuo-Wang Tsai1, Chien-Lin Lu2,3
1Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Biochemia Medica
|August 18, 2025
Summary
This study addresses limitations in the TriNetX platform for analyzing clinical laboratory data. It offers solutions for researchers to effectively query longitudinal laboratory results for retrospective cohort studies.
Area of Science:
- Biomedical Informatics
- Clinical Research Informatics
- Health Data Science
Background:
- TriNetX is a global network of anonymized patient data for retrospective cohort studies.
- Current TriNetX functionality is limited for querying laboratory data, only providing the most recent test result.
- This restricts analysis of laboratory data collected at multiple time points.
Purpose of the Study:
- To introduce innovative, data-informed solutions to overcome TriNetX's limitations in querying longitudinal laboratory data.
- To provide practical guidance for researchers using TriNetX for clinical laboratory data analysis.
- To enhance the utility of TriNetX for detailed retrospective studies involving time-series laboratory measurements.
Main Methods:
- Development of novel querying strategies tailored to TriNetX's data structure.
- Implementation of methods to aggregate and analyze laboratory results across multiple time points within a patient cohort.
- Validation of proposed solutions using simulated or real-world clinical data within the TriNetX environment.
Main Results:
- Demonstrated ability to retrieve and analyze historical laboratory test results beyond the most recent entry.
- Quantified the impact of the new methods on cohort identification and characterization for longitudinal studies.
- Provided a framework for researchers to conduct more sophisticated analyses of laboratory data in TriNetX.
Conclusions:
- The proposed solutions significantly enhance TriNetX's capability for analyzing longitudinal clinical laboratory data.
- Researchers can now perform more comprehensive retrospective studies using multi-time-point laboratory data within TriNetX.
- These advancements improve the value of TriNetX for clinical research requiring detailed temporal laboratory data analysis.
More Related Videos
Related Concept Videos
01:16Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:12Statistical Software for Data Analysis and Clinical Trials
784
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
784
01:25Statistical Methods for Analyzing Epidemiological Data
532
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
532
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:12Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382